Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

BME/PHM stock hub

BME/PHM has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BME/PHMis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.7B

Madrid Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BME/PHM

In the news

Latest news · BME/PHM

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E23.2

P25 n/aP50 n/aP75 n/a

Trailing P/E21.5

P25 n/aP50 n/aP75 n/a

ROE36

P25 n/aP50 n/aP75 n/a

ROIC48.9

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BME/PHM market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

222

Groups with data

Currency

EUR

Showing 222 of 222 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Spain
Country code	ES
Employees	505
Employees Change	5%
Employees Change Percent	1
Enterprise value	EUR 1.6B
Exchange	Madrid Stock Exchange
Financial currency	EUR
First seen	2026-05-10
Industry	Biotechnology
Isin	ES0169501022
Last refreshed	2026-05-10
Market cap	EUR 1.7B
Price	EUR 99.5
Price currency	EUR
Rev Per Employee	446,398.02x
Sector	Healthcare
Sic	2836
Symbol	bme/PHM
Website	https://www.pharmamar.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.66%
EV Earnings	19.97x
EV/EBIT	24.95x
EV/EBITDA	22.26x
EV/FCF	26.48x
EV/Sales	7.13x
FCF yield	3.51%
Forward P/E	23.18x
P/B ratio	6.92x
P/E ratio	21.47x
P/S ratio	7.66x
PE Ratio3 Y	237.2x
PE Ratio5 Y	144.96x
PEG ratio	0.3x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	28.58%
EBITDA Margin	31.17%
FCF margin	26.92%
Gross margin	94.45%
Gross Profit	EUR 212.9M
Gross Profit Growth	28.32%
Gross Profit Growth Q	10.67%
Gross Profit Growth3 Y	8.84%
Gross Profit Growth5 Y	0.84%
Net Income	EUR 80.5M
Net Income Growth	304.85%
Net Income Growth Quarters	2%
Net Income Growth Years	2%
Net Income Growth3 Y	40.86%
Net Income Growth5 Y	-2.4%
Pretax Margin	28.9%
Profit Margin	35.7%
Profit Per Employee	EUR 159,343
Profitable Years	6
ROA	11.2
Roa5y	6.83
ROCE	21.76
ROE	35.99
Roe5y	27.39
ROIC	48.92

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	12.33%
Cagr1y	36.75%
Cagr3y	40.26%
Cagr5y	4.18%
Div CAGR3	14.96%
Div CAGR5	10.48%
EPS Growth Years	2
FCF Growth5 Y	-11.64%
OCF Growth5 Y	-10.28%
Revenue Growth	28.27x
Revenue Growth Q	10.4x
Revenue Growth Quarters	2x
Revenue Growth Years	2x
Revenue Growth3 Y	8.37x
Revenue Growth5 Y	0.33x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.63
Assets	EUR 385.3M
Cash	EUR 167.9M
Current Assets	EUR 273.5M
Current Liabilities	EUR 89.2M
Debt	EUR 47.5M
Debt EBITDA	EUR 0.66
Debt Equity	EUR 0.19
Debt FCF	EUR 0.78
Equity	EUR 249.7M
Interest Coverage	39.28
Liabilities	EUR 135.6M
Long Term Assets	EUR 111.8M
Long Term Liabilities	EUR 46.4M
Net Cash	EUR 120.3M
Net Cash By Market Cap	EUR 6.97
Net Cash Growth	35.33%
Net Debt EBITDA	EUR -1.71
Net Debt Equity	EUR -0.48
Net Debt FCF	EUR -1.98
Tangible Book Value	EUR 245.9M
Tangible Book Value Per Share	EUR 14.16
WACC	6.18

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.06
Inventory Turnover	0.24
Net Working Capital	EUR 29.4M
Quick ratio	2.33
Working Capital	EUR 184.2M
Working Capital Turnover	EUR 1.32

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend Growth	23.08%
Dividend Growth Years	2%
Dividend per share	EUR 0.8
Dividend Years	6
Dividend Yield	0.8%
Ex Div Date	2025-06-25
Last Dividend	EUR 0.8
Payout Frequency	Annual
Payout Ratio	17.33%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	219.66%
1Y total return	36.72%
200-day SMA	82.25
3Y total return	175.98%
50-day SMA	89.6
50-day SMA vs 200-day SMA	50over200
5Y total return	22.73%
All Time High	148
All Time High Change	-32.77%
All Time High Date	2020-10-16
All Time Low	10.45
All Time Low Change	851.97%
All Time Low Date	2018-10-26
ATR	3.6
Beta	0.37
Beta1y	0.57
Beta2y	0.93
Ch YTD	32.84
High	103
High52	105.2
High52 Date	2026-05-07
High52ch	-5.42%
Low	98.25
Low52	70.1
Low52 Date	2025-11-05
Low52ch	41.94%
Ma50ch	11.05%
Price vs 200-day SMA	20.98%
RSI	57.96
RSI Monthly	66.13
RSI Weekly	71.18
Sharpe ratio	0.87x
Sortino ratio	1.42
Total Return	0.8%
Tr YTD	32.84
Tr1m	16.24%
Tr1w	-1.78%
Tr3m	30.49%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 64.4M
Operating Income Growth	738.6
Operating Income Growth3 Y	46.51
Operating Income Growth5 Y	-9.08
Operating margin	28.58

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	13,425,751%
Net Borrowing	-7,259,000
Shares Insiders	12.04%
Shares Institutions	10.43%
Shares Out	17,360,238
Shares Qo Q	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 60.7M
Average Volume	84,306.25x
Bv Per Share	14.38
CAPEX	EUR -7.3M
Ch10y	201.5
Ch1m	16.24
Ch1w	-1.78
Ch1y	35.37
Ch3m	30.49
Ch3y	164.8
Ch5y	16.84
Ch6m	39.85
Change	-3.21%
Change From Open	-3.4
Close	102.8
Days Gap	0.19
Depreciation Amortization	5,852,000
Dollar Volume	8,431,829
Earnings Date	2026-04-29
EBIT	EUR 64.4M
EBITDA	EUR 70.3M
EPS	EUR 4.64
F Score	7
FCF	EUR 60.7M
FCF EV Yield	3.78x
FCF Per Share	EUR 3.5
Financing CF	-36,735,000
Fiscal Year End	December
Founded	1,986
Graham Number	38.72855
Graham Upside	-61.08
Income Tax	EUR -15.3M
Investing CF	-43,088,000
Is Primary Listing	1
Last Earnings Date	2026-04-29
Last Report Date	2026-03-31
Last Split Date	2020-07-22
Last Split Type	Reverse
Lynch Fair Value	EUR 23.18
Lynch Upside	-76.71
Ma150	81.54
Ma150ch	22.03%
Ma20	97.23
Ma20ch	2.33%
Net CF	-11,427,000
Next Earnings Date	2026-07-27
Open	103
P FCF Ratio	28.46
P OCF Ratio	25.4
Payment Date	2025-06-27
Position In Range	26.32
Ppne	59,657,000
Price Date	2026-05-08
Price EBITDA	EUR 24.58
Ptbv Ratio	7.03
Relative Volume	1.02x
Revenue	225,431,000x
Tax By Revenue	-6.79x
Tr6m	39.85%
Volume	84,742
Z Score	8.74

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

BME/PHM dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.8%

$0.80 annual per share

Payout ratio

+17.3%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+10.5%

2 consecutive years of growth

Total shareholder yield

+0.8%

Next ex-dividend date: 2025-06-25

Performance

BME/PHM stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BME/PHM?

Insider, institutional, and short-interest positioning.

Institutional ownership

+10.4%

Share of float held by funds and institutions

Insider ownership

+12.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

BME/PHM momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

58.0

Neutral momentum band

Price vs 200-day MA

+21.0%

50/200-day relationship not available

Beta (5Y)

0.37

Less volatile than the market

Sharpe ratio

0.87

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BME/PHM

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bme/PHM stock rating?

bme/PHM is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bme/PHM analysis?

The full report lives at /stocks/bme/PHM/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bme/PHM?

The latest report frames bme/PHM around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bme/PHM page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.